{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:05:31Z","timestamp":1785150331278,"version":"3.55.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Anhui province clinical medical research transformation project","award":["NO.202304295107020041; NO.202304295107020048"],"award-info":[{"award-number":["NO.202304295107020041; NO.202304295107020048"]}]},{"name":"he Science and Technology Development Fund of Pudong New Area","award":["No. PKJ2023-Y36"],"award-info":[{"award-number":["No. PKJ2023-Y36"]}]},{"name":"Young Medical Talents Training Program of Pudong Health Bureau of Shanghai","award":["Grant No. PWRq2022-01"],"award-info":[{"award-number":["Grant No. PWRq2022-01"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["no. 82073652"],"award-info":[{"award-number":["no. 82073652"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chinese Research Funds of Joint Research Center for Occupational Medicine and Health of IHM","award":["OMH-2023-01;OMH-2023-08"],"award-info":[{"award-number":["OMH-2023-01;OMH-2023-08"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-03041-8","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:16:54Z","timestamp":1770819414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The shared genetic architecture underlying the autoimmune and cardiovascular disease: a multivariate genome-wide analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianling","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"3041_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","volume":"19","author":"DS Pisetsky","year":"2023","unstructured":"Pisetsky DS. Pathogenesis of autoimmune disease. Nat Rev Nephrol. 2023;19:509\u201324. https:\/\/doi.org\/10.1038\/s41581-023-00720-1.","journal-title":"Nat Rev Nephrol"},{"issue":"10354","key":"3041_CR2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","volume":"400","author":"N Conrad","year":"2022","unstructured":"Conrad N, Verbeke G, Molenberghs G, et al. Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK. Lancet. 2022;400(10354):733\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(22)01349-6.","journal-title":"Lancet"},{"issue":"7","key":"3041_CR3","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm.3897","volume":"21","author":"JH Cho","year":"2015","unstructured":"Cho JH, Feldman M. Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies. Nat Med. 2015;21(7):730\u20138. https:\/\/doi.org\/10.1038\/nm.3897.","journal-title":"Nat Med"},{"key":"3041_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1126\/science.adg2992","volume":"380","author":"A Harroud","year":"2023","unstructured":"Harroud A, Hafler DA. Common genetic factors among autoimmune diseases. Science. 2023;380:485\u201390. https:\/\/doi.org\/10.1126\/science.adg2992.","journal-title":"Science"},{"issue":"6","key":"3041_CR5","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.cell.2012.03.001","volume":"148","author":"S Kathiresan","year":"2012","unstructured":"Kathiresan S, Srivastava D. Genetics of human cardiovascular disease. Cell. 2012;148(6):1242\u201357. https:\/\/doi.org\/10.1016\/j.cell.2012.03.001.","journal-title":"Cell"},{"key":"3041_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.030211","author":"Y Guo","year":"2023","unstructured":"Guo Y, Chung W, Shan Z, Zhu Z, Costenbader KH, Liang L. Genome-wide assessment of shared genetic architecture between rheumatoid arthritis and cardiovascular diseases. J Am Heart Assoc. 2023. https:\/\/doi.org\/10.1161\/JAHA.123.030211.","journal-title":"J Am Heart Assoc"},{"key":"3041_CR7","doi-asserted-by":"publisher","first-page":"eabf7600","DOI":"10.1126\/sciadv.abd7600","volume":"7","author":"F Szymczak","year":"2021","unstructured":"Szymczak F, et al. Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis, and rheumatoid arthritis. Sci Adv. 2021;7:eabf7600. https:\/\/doi.org\/10.1126\/sciadv.abd7600.","journal-title":"Sci Adv"},{"issue":"5","key":"3041_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41562-019-0566-x","volume":"3","author":"AD Grotzinger","year":"2019","unstructured":"Grotzinger AD, Rhemtulla M, de Vlaming R, et al. Genomic structural equation modelling provides insights into the multivariate genetic architecture of complex traits. Nat Hum Behav. 2019;3(5):513\u201325. https:\/\/doi.org\/10.1038\/s41562-019-0566-x.","journal-title":"Nat Hum Behav"},{"key":"3041_CR9","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41588-022-01213-w","volume":"54","author":"K Ishigaki","year":"2022","unstructured":"Ishigaki K, Sakaue S, Terao C, et al. Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis. Nat Genet. 2022;54:1640\u201351. https:\/\/doi.org\/10.1038\/s41588-022-01213-w.","journal-title":"Nat Genet"},{"key":"3041_CR10","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41586-021-03552-w","volume":"594","author":"J Chiou","year":"2021","unstructured":"Chiou J, Geusz RJ, Okino ML, et al. Interpreting type 1 diabetes risk with genetics and single-cell epigenomics. Nature. 2021;594:398\u2013402. https:\/\/doi.org\/10.1038\/s41586-021-03552-w.","journal-title":"Nature"},{"key":"3041_CR11","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/ng.3434","volume":"47","author":"J Bentham","year":"2015","unstructured":"Bentham J, Morris D, Cunninghame Graham D, et al. Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet. 2015;47:1457\u201364. https:\/\/doi.org\/10.1038\/ng.3434.","journal-title":"Nat Genet"},{"key":"3041_CR12","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/s41588-022-01233-6","volume":"54","author":"KG Aragam","year":"2022","unstructured":"Aragam KG, Jiang T, Goel A, et al. Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants. Nat Genet. 2022;54:1803\u201315. https:\/\/doi.org\/10.1038\/s41588-022-01233-6.","journal-title":"Nat Genet"},{"key":"3041_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41467-019-13690-5","volume":"11","author":"S Shah","year":"2020","unstructured":"Shah S, Henry A, Roselli C, et al. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat Commun. 2020;11:163. https:\/\/doi.org\/10.1038\/s41467-019-13690-5.","journal-title":"Nat Commun"},{"key":"3041_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-022-05165-3","volume":"611","author":"A Mishra","year":"2022","unstructured":"Mishra A, Malik R, Hachiya T, et al. Stroke genetics informs drug discovery and risk prediction across ancestries. Nature. 2022;611:115\u201323. https:\/\/doi.org\/10.1038\/s41586-022-05165-3.","journal-title":"Nature"},{"issue":"5","key":"3041_CR15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.119.002862","volume":"14","author":"NR van Zuydam","year":"2021","unstructured":"van Zuydam NR, Stiby A, Abdalla M, et al. Genome-wide association study of peripheral artery disease. Circ Genom Precis Med. 2021;14(5):e002862. https:\/\/doi.org\/10.1161\/CIRCGEN.119.002862.","journal-title":"Circ Genom Precis Med"},{"key":"3041_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/ng.3211","volume":"47","author":"B Bulik-Sullivan","year":"2015","unstructured":"Bulik-Sullivan B, Loh PR, Finucane H, et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015;47:291\u20135.","journal-title":"Nat Genet"},{"key":"3041_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41588-022-01017-y","volume":"54","author":"J Werme","year":"2022","unstructured":"Werme J, van der Sluis S, Posthuma D, et al. An integrated framework for local genetic correlation analysis. Nat Genet. 2022;54:274\u201382. https:\/\/doi.org\/10.1038\/s41588-022-01017-y.","journal-title":"Nat Genet"},{"key":"3041_CR18","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41467-017-01261-5","volume":"8","author":"K Watanabe","year":"2017","unstructured":"Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8:1826.","journal-title":"Nat Commun"},{"key":"3041_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ng.2213","volume":"44","author":"J Yang","year":"2012","unstructured":"Yang J, et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat Genet. 2012;44:369\u201375.","journal-title":"Nat Genet"},{"issue":"7","key":"3041_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010299","volume":"18","author":"Y Zou","year":"2022","unstructured":"Zou Y, Carbonetto P, Wang G, Stephens M. Fine-mapping from summary data with the \u201cSum of Single Effects\u201d model. PLoS Genet. 2022;18(7):e1010299. https:\/\/doi.org\/10.1371\/journal.pgen.1010299.","journal-title":"PLoS Genet"},{"issue":"10","key":"3041_CR21","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/bioinformatics\/btw018","volume":"32","author":"C Benner","year":"2016","unstructured":"Benner C, Spencer CC, Havulinna AS, Salomaa V, Ripatti S, Pirinen M. FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics. 2016;32(10):1493\u2013501. https:\/\/doi.org\/10.1093\/bioinformatics\/btw018.","journal-title":"Bioinformatics"},{"key":"3041_CR22","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/ng.3404","volume":"47","author":"HK Finucane","year":"2015","unstructured":"Finucane HK, et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat Genet. 2015;47:1228\u201335.","journal-title":"Nat Genet"},{"key":"3041_CR23","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41588-018-0081-4","volume":"50","author":"HK Finucane","year":"2018","unstructured":"Finucane HK, et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Nat Genet. 2018;50:621\u20139.","journal-title":"Nat Genet"},{"key":"3041_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004219","volume":"11","author":"CA de Leeuw","year":"2015","unstructured":"de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol. 2015;11:e1004219.","journal-title":"PLoS Comput Biol"},{"key":"3041_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bioinformatics\/btaa1096","volume":"37","author":"MK Sobczyk","year":"2021","unstructured":"Sobczyk MK, Gaunt TR, Paternoster L. MendelVar: gene prioritization at GWAS loci using phenotypic enrichment of Mendelian disease genes. Bioinformatics. 2021;37:1\u20138.","journal-title":"Bioinformatics"},{"key":"3041_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng.3506","volume":"48","author":"A Gusev","year":"2016","unstructured":"Gusev A, et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet. 2016;48:245\u201352.","journal-title":"Nat Genet"},{"issue":"4","key":"3041_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008973","volume":"17","author":"H Feng","year":"2021","unstructured":"Feng H, Mancuso N, Gusev A, et al. Leveraging expression from multiple tissues using sparse canonical correlation analysis and aggregate tests improves the power of transcriptome-wide association studies. PLoS Genet. 2021;17(4):e1008973.","journal-title":"PLoS Genet"},{"key":"3041_CR28","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41588-019-0367-1","volume":"51","author":"N Mancuso","year":"2019","unstructured":"Mancuso N, et al. Probabilistic fine-mapping of transcriptome-wide association studies. Nat Genet. 2019;51:675\u201382.","journal-title":"Nat Genet"},{"issue":"5795","key":"3041_CR29","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D, et al. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313(5795):1929\u201335. https:\/\/doi.org\/10.1126\/science.1132939.","journal-title":"Science"},{"key":"3041_CR30","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","volume":"52","author":"J Zheng","year":"2020","unstructured":"Zheng J, et al. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat Genet. 2020;52:1122\u201331.","journal-title":"Nat Genet"},{"key":"3041_CR31","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41591-021-01310-z","volume":"27","author":"L Gaziano","year":"2021","unstructured":"Gaziano L, et al. Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19. Nat Med. 2021;27:668\u201376.","journal-title":"Nat Med"},{"key":"3041_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"Bycroft","year":"2018","unstructured":"Bycroft, Freeman C, Petkova D, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203\u20139.","journal-title":"Nature"},{"key":"3041_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giz082","volume":"8","author":"SW Choi","year":"2019","unstructured":"Choi SW, O\u2019Reilly PF. PRSice-2: polygenic risk score software for biobank-scale data. Gigascience. 2019;8:giz082. https:\/\/doi.org\/10.1093\/gigascience\/giz082.","journal-title":"Gigascience"},{"issue":"1","key":"3041_CR34","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.cell.2013.08.041","volume":"155","author":"V Orr\u00f9","year":"2013","unstructured":"Orr\u00f9 V, Steri M, Sole G, et al. Genetic variants regulating immune cell levels in health and disease. Cell. 2013;155(1):242\u201356. https:\/\/doi.org\/10.1016\/j.cell.2013.08.041.","journal-title":"Cell"},{"issue":"2","key":"3041_CR35","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1161\/CIRCGENETICS.114.000527","volume":"8","author":"MJ Flister","year":"2015","unstructured":"Flister MJ, Hoffman MJ, Lemke A, et al. SH2B3 is a genetic determinant of cardiac inflammation and fibrosis. Circ Cardiovasc Genet. 2015;8(2):294\u2013304. https:\/\/doi.org\/10.1161\/CIRCGENETICS.114.000527.","journal-title":"Circ Cardiovasc Genet"},{"issue":"25","key":"3041_CR36","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1016\/j.jacc.2010.02.044","volume":"55","author":"M Benn","year":"2010","unstructured":"Benn M, Nordestgaard BG, Grande P, Schnohr P, Tybjaerg-Hansen A. PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses. J Am Coll Cardiol. 2010;55(25):2833\u201342. https:\/\/doi.org\/10.1016\/j.jacc.2010.02.044.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3041_CR37","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.118.002196","volume":"12","author":"CP Nelson","year":"2019","unstructured":"Nelson CP, Lai FY, Nath M, et al. Genetic assessment of potential long-term on-target side effects of PCSK9 (proprotein convertase subtilisin\/kexin type 9) inhibitors. Circ Genom Precis Med. 2019;12(1):e002196. https:\/\/doi.org\/10.1161\/CIRCGEN.118.002196.","journal-title":"Circ Genom Precis Med"},{"issue":"9","key":"3041_CR38","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1177\/0961203314530019","volume":"23","author":"CP Chung","year":"2014","unstructured":"Chung CP, Solus JF, Oeser A, et al. Genetic variation and coronary atherosclerosis in patients with systemic lupus erythematosus. Lupus. 2014;23(9):876\u201380. https:\/\/doi.org\/10.1177\/0961203314530019.","journal-title":"Lupus"},{"key":"3041_CR39","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/s41591-021-01452-0","volume":"27","author":"GA Lewis","year":"2021","unstructured":"Lewis GA, Dodd S, Clayton D, et al. Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial. Nat Med. 2021;27:1477\u201382. https:\/\/doi.org\/10.1038\/s41591-021-01452-0.","journal-title":"Nat Med"},{"issue":"11","key":"3041_CR40","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1161\/CIRCRESAHA.121.3190774(10):1638-1647","volume":"128","author":"PM Ridker","year":"2021","unstructured":"Ridker PM, Rane M. Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease. Circ Res. 2021;128(11):1728\u201346. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.3190774(10):1638-1647.","journal-title":"Circ Res"},{"issue":"6","key":"3041_CR41","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1016\/S2666-7568(21)00061-1","volume":"2","author":"J Pedro Ferreira","year":"2021","unstructured":"Pedro Ferreira J, Pitt B, Zannad F. Histone deacetylase inhibitors for cardiovascular conditions and healthy longevity. Lancet Healthy Longev. 2021;2(6):e371\u20139. https:\/\/doi.org\/10.1016\/S2666-7568(21)00061-1.","journal-title":"Lancet Healthy Longev"},{"key":"3041_CR42","doi-asserted-by":"publisher","DOI":"10.1101\/2024.09.01.24310190","author":"J Qiao","year":"2024","unstructured":"Qiao J, Chang M, Chen M, Zhao Y, Hao J, Zhang P, et al. Genetic analyses identify shared genetic components related to autoimmune and cardiovascular diseases. medRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.09.01.24310190.","journal-title":"medRxiv"},{"issue":"10","key":"3041_CR43","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/art.42239","volume":"74","author":"S Yuan","year":"2022","unstructured":"Yuan S, Carter P, Mason AM, Yang F, Burgess S, Larsson SC. Genetic liability to rheumatoid arthritis in relation to coronary artery disease and stroke risk. Arthritis Rheumatol. 2022;74(10):1638\u201347. https:\/\/doi.org\/10.1002\/art.42239.","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"3041_CR44","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1007\/s00125-024-06247-9","volume":"67","author":"J Adebekun","year":"2024","unstructured":"Adebekun J, Nadig A, Saarah P, Asgari S, Kachuri L, Alagpulinsa DA. Genetic relations between type 1 diabetes, coronary artery disease and leukocyte counts. Diabetologia. 2024;67(11):2518\u201329. https:\/\/doi.org\/10.1007\/s00125-024-06247-9.","journal-title":"Diabetologia"},{"issue":"3","key":"3041_CR45","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.semarthrit.2021.03.004","volume":"51","author":"K Tizaoui","year":"2021","unstructured":"Tizaoui K, Terrazzino S, Cargnin S, et al. The role of PTPN22 in the pathogenesis of autoimmune diseases: a comprehensive review. Semin Arthritis Rheum. 2021;51(3):513\u201322. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.03.004.","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"3041_CR46","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1172\/JCI66963","volume":"123","author":"X Dai","year":"2013","unstructured":"Dai X, James RG, Habib T, et al. A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models. J Clin Invest. 2013;123(5):2024\u201336. https:\/\/doi.org\/10.1172\/JCI66963.","journal-title":"J Clin Invest"},{"issue":"1","key":"3041_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/1744666X.2022.2017281","volume":"18","author":"J Frosteg\u00e5rd","year":"2022","unstructured":"Frosteg\u00e5rd J. The role of PCSK9 in inflammation, immunity, and autoimmune diseases. Expert Rev Clin Immunol. 2022;18(1):67\u201374. https:\/\/doi.org\/10.1080\/1744666X.2022.2017281.","journal-title":"Expert Rev Clin Immunol"},{"key":"3041_CR48","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X20975904","volume":"12","author":"H Sanchez-Perez","year":"2020","unstructured":"Sanchez-Perez H, Quevedo-Abeledo JC, Tejera-Segura B, et al. Proprotein convertase subtilisin\/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus. Ther Adv Musculoskelet Dis. 2020;12:1759720X20975904.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"3041_CR49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13075-020-02386-7","volume":"23","author":"J Frostegard","year":"2021","unstructured":"Frostegard J, Ahmed S, Hafstrom I, et al. Low levels of PCSK9 are associated with remission in patients with rheumatoid arthritis treated with anti-TNF-alpha: potential underlying mechanisms. Arthritis Res Ther. 2021;23(1):32.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"3041_CR50","doi-asserted-by":"publisher","first-page":"e145","DOI":"10.1161\/ATVBAHA.118.310802","volume":"38","author":"M Centa","year":"2018","unstructured":"Centa M, Prokopec KE, Garimella MG, et al. Acute loss of apolipoprotein E triggers an autoimmune response that accelerates atherosclerosis. Arterioscler Thromb Vasc Biol. 2018;38(8):e145\u201358. https:\/\/doi.org\/10.1161\/ATVBAHA.118.310802.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3041_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-024-01045-7","author":"F Porsch","year":"2024","unstructured":"Porsch F, Binder CJ. Autoimmune diseases and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 2024. https:\/\/doi.org\/10.1038\/s41569-024-01045-7.","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"3041_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110715","volume":"27","author":"S Kerns","year":"2024","unstructured":"Kerns S, Owen KA, Daamen A, Kain J, Grammer AC, Lipsky PE. Genetic association with autoimmune diseases identifies molecular mechanisms of coronary artery disease. iScience. 2024;27(9):110715. https:\/\/doi.org\/10.1016\/j.isci.2024.110715.","journal-title":"iScience"},{"key":"3041_CR53","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41581-023-00797-8","volume":"20","author":"WG Ambler","year":"2024","unstructured":"Ambler WG, Kaplan MJ. Vascular damage in systemic lupus erythematosus. Nat Rev Nephrol. 2024;20:251\u201365. https:\/\/doi.org\/10.1038\/s41581-023-00797-8.","journal-title":"Nat Rev Nephrol"},{"key":"3041_CR54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41584-023-00969-7","volume":"19","author":"BN Weber","year":"2023","unstructured":"Weber BN, Giles JT, Liao KP. Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease. Nat Rev Rheumatol. 2023;19:417\u201328. https:\/\/doi.org\/10.1038\/s41584-023-00969-7.","journal-title":"Nat Rev Rheumatol"},{"key":"3041_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2023.06.005","volume":"394","author":"B Verg\u00e8s","year":"2024","unstructured":"Verg\u00e8s B. Cardiovascular disease in type 1 diabetes, an underestimated danger: epidemiological and pathophysiological data. Atherosclerosis. 2024;394:117158. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.06.005.","journal-title":"Atherosclerosis"},{"issue":"11","key":"3041_CR56","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1161\/01.RES.0000191547.64391.e3","volume":"97","author":"GE Davis","year":"2005","unstructured":"Davis GE, Senger DR. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res. 2005;97(11):1093\u2013107. https:\/\/doi.org\/10.1161\/01.RES.0000191547.64391.e3.","journal-title":"Circ Res"},{"issue":"7","key":"3041_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006127","volume":"12","author":"W Yang","year":"2016","unstructured":"Yang W, Ng FL, Chan K, et al. Coronary-heart-disease-associated genetic variant at the COL4A1\/COL4A2 locus affects COL4A1\/COL4A2 expression, vascular cell survival, atherosclerotic plaque stability and risk of myocardial infarction. PLoS Genet. 2016;12(7):e1006127. https:\/\/doi.org\/10.1371\/journal.pgen.1006127.","journal-title":"PLoS Genet"},{"key":"3041_CR58","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","volume":"41","author":"J Bor\u00e9n","year":"2020","unstructured":"Bor\u00e9n J, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2020;41:2313\u201330.","journal-title":"Eur Heart J"},{"key":"3041_CR59","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3520","volume":"13","author":"KJ Moore","year":"2013","unstructured":"Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol. 2013;13:709\u201321.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3041_CR60","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.rdc.2022.07.006","volume":"49","author":"N Ronda","year":"2023","unstructured":"Ronda N, Zimetti F, Adorni MP, Palumbo M, Karpouzas GA, Bernini F. Role of lipoprotein levels and function in atherosclerosis associated with autoimmune rheumatic diseases. Rheum Dis Clin North Am. 2023;49(1):151\u201363. https:\/\/doi.org\/10.1016\/j.rdc.2022.07.006.","journal-title":"Rheum Dis Clin North Am"},{"key":"3041_CR61","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","volume":"379","author":"N Sarwar","year":"2012","unstructured":"Sarwar N, Butterworth AS, Freitag DF, Gregson J, Willeit P, Gorman DN, et al. IL6R genetics consortium emerging risk factors collaboration. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet. 2012;379:1205\u201313. https:\/\/doi.org\/10.1016\/S0140-6736(11)61931-4.","journal-title":"Lancet"},{"key":"3041_CR62","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","volume":"379","author":"DI Swerdlow","year":"2012","unstructured":"Swerdlow DI, Holmes MV, Kuchenbaecker KB, Engmann JE, Shah T, Sofat R, et al. Interleukin-6 receptor mendelian randomisation analysis (IL6R MR) consortium. The interleukin-6 receptor as a target for prevention of coronary heart disease: a Mendelian randomisation analysis. Lancet. 2012;379:1214\u201324. https:\/\/doi.org\/10.1016\/S0140-6736(12)60110-X.","journal-title":"Lancet"},{"key":"3041_CR63","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/jamacardio.2018.2287","volume":"3","author":"T Cai","year":"2018","unstructured":"Cai T, Zhang Y, Ho YL, Link N, Sun J, Huang J, et al. Association of interleukin 6 receptor variant with cardiovascular disease effects of interleukin 6 receptor blocking therapy: a phenome-wide association study. JAMA Cardiol. 2018;3:849\u201357. https:\/\/doi.org\/10.1001\/jamacardio.2018.2287.","journal-title":"JAMA Cardiol"},{"key":"3041_CR64","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005038","volume":"6","author":"BC Bacchiega","year":"2017","unstructured":"Bacchiega BC, et al. Interleukin 6 inhibition and coronary artery disease in a high\u2010risk population: a prospective community\u2010based clinical study. J Am Heart Assoc. 2017;6:e005038.","journal-title":"J Am Heart Assoc"},{"key":"3041_CR65","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.atherosclerosis.2011.09.015","volume":"219","author":"AD Protogerou","year":"2011","unstructured":"Protogerou AD, et al. A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis. Atherosclerosis. 2011;219:734\u20136.","journal-title":"Atherosclerosis"},{"issue":"1","key":"3041_CR66","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/annrheumdis-2013-204133","volume":"74","author":"A Yarwood","year":"2015","unstructured":"Yarwood A, Han B, Raychaudhuri S, et al. A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis risk. Ann Rheum Dis. 2015;74(1):170\u20136. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204133.","journal-title":"Ann Rheum Dis"},{"issue":"545","key":"3041_CR67","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay1548","volume":"12","author":"R Knevel","year":"2020","unstructured":"Knevel R, le Cessie S, Terao CC, et al. Using genetics to prioritize diagnoses for rheumatology outpatients with inflammatory arthritis. Sci Transl Med. 2020;12(545):eaay1548. https:\/\/doi.org\/10.1126\/scitranslmed.aay1548.","journal-title":"Sci Transl Med"},{"issue":"8","key":"3041_CR68","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001077","volume":"146","author":"JW O'Sullivan","year":"2022","unstructured":"O\u2019Sullivan JW, Raghavan S, Marquez-Luna C, et al. Polygenic risk scores for cardiovascular disease: a scientific statement from the american heart association. Circulation. 2022;146(8):e93\u2013118. https:\/\/doi.org\/10.1161\/CIR.0000000000001077.","journal-title":"Circulation"},{"key":"3041_CR69","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13073-020-00742-5","volume":"12","author":"CM Lewis","year":"2020","unstructured":"Lewis CM, Vassos E. Polygenic risk scores: from research tools to clinical instruments. Genome Med. 2020;12:44. https:\/\/doi.org\/10.1186\/s13073-020-00742-5.","journal-title":"Genome Med"},{"key":"3041_CR70","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrrheum.2012.138","volume":"8","author":"JM Vallat","year":"2012","unstructured":"Vallat JM, Rabin M, Magy L. Peripheral neuropathies in rheumatic disease\u2014a guide to diagnosis. Nat Rev Rheumatol. 2012;8:599\u2013609. https:\/\/doi.org\/10.1038\/nrrheum.2012.138.","journal-title":"Nat Rev Rheumatol"},{"key":"3041_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0092-1","volume":"5","author":"EL Feldman","year":"2019","unstructured":"Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5:41. https:\/\/doi.org\/10.1038\/s41572-019-0092-1.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"3041_CR72","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001152","volume":"11","author":"CY Wong","year":"2024","unstructured":"Wong CY, Ma BMY, Zhang D, Cheung W, Chan TM, Yap DYH. Cardiovascular risk factors and complications in patients with systemic lupus erythematosus with and without nephritis: a systematic review and meta-analysis. Lupus Sci Med. 2024;11(1):e001152. https:\/\/doi.org\/10.1136\/lupus-2024-001152.","journal-title":"Lupus Sci Med"},{"key":"3041_CR73","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/annrheumdis-2011-200051","volume":"71","author":"AM van Sijl","year":"2012","unstructured":"van Sijl AM, van den Oever IA, Peters MJ, Boers M, Dijkmans BA, van Halm VP, et al. Subclinical renal dysfunction is independently associated with cardiovascular events in rheumatoid arthritis: the CARRE Study. Ann Rheum Dis. 2012;71:341\u20134. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200051.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"3041_CR74","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S2213-8587(23)00168-7ne.0136508","volume":"11","author":"HJ Heerspink","year":"2023","unstructured":"Heerspink HJ, Cherney DZ, Groop PH, et al. People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action. Lancet Diabetes Endocrinol. 2023;11(8):536\u201340. https:\/\/doi.org\/10.1016\/S2213-8587(23)00168-7ne.0136508.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"3041_CR75","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bpsgos.2021.03.002","volume":"1","author":"KP Glanville","year":"2021","unstructured":"Glanville KP, Coleman JRI, O\u2019Reilly PF, Galloway J, Lewis CM. Investigating pleiotropy between depression and autoimmune diseases using the UK Biobank. Biol Psychiatry Glob Open Sci. 2021;1(1):48\u201358. https:\/\/doi.org\/10.1016\/j.bpsgos.2021.03.002.","journal-title":"Biol Psychiatry Glob Open Sci"},{"key":"3041_CR76","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/s44161-024-00488-y","volume":"3","author":"J Bergstedt","year":"2024","unstructured":"Bergstedt J, Pasman JA, Ma Z, et al. Distinct biological signature and modifiable risk factors underlie the comorbidity between major depressive disorder and cardiovascular disease. Nat Cardiovasc Res. 2024;3:754\u201369. https:\/\/doi.org\/10.1038\/s44161-024-00488-y.","journal-title":"Nat Cardiovasc Res"},{"key":"3041_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008489","volume":"15","author":"EA King","year":"2019","unstructured":"King EA, Davis JW, Degner JF. Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS Genet. 2019;15:e1008489.","journal-title":"PLoS Genet"},{"key":"3041_CR78","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3314","volume":"47","author":"MR Nelson","year":"2015","unstructured":"Nelson MR, et al. The support of human genetic evidence for approved drug indications. Nat Genet. 2015;47:856\u201360.","journal-title":"Nat Genet"},{"key":"3041_CR79","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41584-024-01096-7","volume":"20","author":"VL Kronzer","year":"2024","unstructured":"Kronzer VL, Sparks JA, Raychaudhuri S, et al. Low-frequency and rare genetic variants associated with rheumatoid arthritis risk. Nat Rev Rheumatol. 2024;20:290\u2013300. https:\/\/doi.org\/10.1038\/s41584-024-01096-7.","journal-title":"Nat Rev Rheumatol"},{"key":"3041_CR80","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1038\/s41467-019-10242-9","volume":"10","author":"SH Jiang","year":"2019","unstructured":"Jiang SH, Athanasopoulos V, Ellyard JI, et al. Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus. Nat Commun. 2019;10:2201. https:\/\/doi.org\/10.1038\/s41467-019-10242-9.","journal-title":"Nat Commun"},{"issue":"4","key":"3041_CR81","doi-asserted-by":"publisher","first-page":"784","DOI":"10.2337\/db19-0831","volume":"69","author":"V Forgetta","year":"2020","unstructured":"Forgetta V, Manousaki D, Istomine R, et al. Rare genetic variants of large effect influence risk of type 1 diabetes. Diabetes. 2020;69(4):784\u201395. https:\/\/doi.org\/10.2337\/db19-0831.","journal-title":"Diabetes"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-03041-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-03041-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-03041-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:12:56Z","timestamp":1770883976000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-025-03041-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3041"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-03041-8","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"44"}}